沪深市场个股详情

300015 爱尔眼科

添加自选

13.12
+0.49+3.88%

已收盘 04/29 15:00 (北京)

1223.89亿总市值35.17市盈率TTM

爱尔眼科股票讨论区

登录发表评论

Moomoo AI

03/06 15:47

Aier Eye Hospital Group could become a multi-bagger due to its high capital compounding rates. Despite higher stock prices, strong fundamentals warrant further research.

Why You Should Care About Aier Eye Hospital Group's (SZSE:300015) Strong Returns On Capital

Moomoo AI

01/21 11:10

Despite the recent decline in share price, long-term investors have seen a 15% return each year over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering.

Aier Eye Hospital Group's (SZSE:300015) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth

Moomoo AI

2023/12/22 18:12

Aier Eye Hospital Group's high P/E ratio, despite weaker growth predictions, pose risks for investors. The high P/E amidst lower growth forecasts suggest a potential for declining value in investments.

Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) Share Price Could Signal Some Risk

Moomoo AI

2023/12/06 11:17

Aier Eye Hospital Group shows promising trends, hinting at potential multi-bagger status. High ROCE and continuous capital reinvestment suggest a bright future, but further research is advised due to strong performance.

Aier Eye Hospital Group (SZSE:300015) Is Aiming To Keep Up Its Impressive Returns

Moomoo AI

2023/10/11 14:36

市场扩张阶段，头部民营眼科公司将占更大市场份额。关键竞争力源自品牌口碑、医生团队、医疗设备。但应防民营医院政策、医保控费风险，扩张速度低于预期的风险，及管理与人才风险。

东方财富：上半年民营眼科服务公司业绩增长显著市场仍处于扩张阶段

暂无评论

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议

沪深

综合热度